Evidence map›Paper›PMID 34073017›Full record

ArticleMicroorganisms2021

Morinagadepsin, a Depsipeptide from the Fungus

Karen Harms, Frank Surup, Marc Stadler, Alberto Miguel Stchigel, Yasmina Marin-Felix

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. New sordarialean lineageIMA fungus · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Reaping the Chemical Diversity ofJournal of natural products · 2024
    Article
  9. Article
  10. Article
  11. Heimionones A-E, New Sesquiterpenoids Produced byMolecules (Basel, Switzerland) · 2023
    Article
  12. Journal of fungi (Basel, Switzerland) · 2023
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Karen HarmsDepartment Microbial Drugs, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany.ORCID 0000-0002-5867-0846
Frank SurupDepartment Microbial Drugs, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany.ORCID 0000-0001-5234-8525
Marc StadlerDepartment Microbial Drugs, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany.ORCID 0000-0002-7284-8671
Alberto Miguel StchigelMycology Unit, Medical School and IISPV, Universitat Rovira i Virgili, C/ Sant Llorenç 21, Tarragona, 43201 Reus, Spain.ORCID 0000-0003-3987-7996
Yasmina Marin-FelixDepartment Microbial Drugs, Helmholtz Centre for Infection Research, Inhoffenstrasse 7, 38124 Braunschweig, Germany.
Helmholtz Centre for Infection Research · DEInstitut de Recerca Biomèdica Catalunya Sud · ES

Funding

Alexander von Humboldt-Stiftung No number
6 · The paper itself

Abstract

The new genus

Indexed as

cytotoxicitydepsipeptidemorinagadepsinMorinagamycesSchizotheciaceaesecondary metabolitesSordariales

Identifiers

PMID34073017
PMCPMC8230337
OpenAlexW3164867977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.